Alger Concentrated Equity ETF Outperformed Russell 1000 Growth in Q2 2026
A single actively managed ETF beating its benchmark in one quarter does not confirm sustained outperformance, but the result adds a data point to the ongoing debate over concentrated equity...
The Alger Concentrated Equity ETF (ticker: CNEQ) outperformed the Russell 1000 Growth Index during the second quarter of 2026, according to the fund's Q2 2026 Commentary published on Seeking Alpha. The fund reported a net asset value of $41.07 per share and a closing price of $41.27 as of June 30, 2026, per the same commentary.
The fund launched on April 4, 2024, giving it approximately two years and two months of operating history as of the reporting date. Its gross expense ratio stands at 0.66 percent, according to the Q2 2026 fund snapshot included in the Seeking Alpha disclosure.
The specific margin by which CNEQ outperformed the Russell 1000 Growth Index during Q2 2026 was not disclosed in the source material reviewed by The Congressional Times. The full quarterly return figures, along with any attribution analysis, would be contained in the complete Q2 2026 Commentary filed or published by Alger. Readers seeking the precise performance differential should consult that document directly.
Concentrated equity strategies typically hold a smaller number of individual positions than broad index funds, which can amplify both gains and losses relative to a benchmark during any given period. Whether CNEQ's Q2 result reflects a systematic advantage or quarter-specific factor exposure is not determinable from the available disclosure alone. Cumulative performance data spanning the fund's full operating history since April 2024 would provide a more complete basis for evaluating the strategy.